Page last updated: 2024-09-03

8-(dicyclopropylmethyl)-1,3-dipropylxanthine and kf 17837

8-(dicyclopropylmethyl)-1,3-dipropylxanthine has been researched along with kf 17837 in 1 studies

Compound Research Comparison

Studies
(8-(dicyclopropylmethyl)-1,3-dipropylxanthine)
Trials
(8-(dicyclopropylmethyl)-1,3-dipropylxanthine)
Recent Studies (post-2010)
(8-(dicyclopropylmethyl)-1,3-dipropylxanthine)
Studies
(kf 17837)
Trials
(kf 17837)
Recent Studies (post-2010) (kf 17837)
1400800

Protein Interaction Comparison

ProteinTaxonomy8-(dicyclopropylmethyl)-1,3-dipropylxanthine (IC50)kf 17837 (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.062
Adenosine receptor A2aHomo sapiens (human)0.001
Adenosine receptor A2bHomo sapiens (human)1.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuse, E; Ichikawa, S; Ishii, A; Kobayashi, H; Nakamura, J; Nonaka, H; Shimada, J; Shiozaki, S; Suzuki, F1

Other Studies

1 other study(ies) available for 8-(dicyclopropylmethyl)-1,3-dipropylxanthine and kf 17837

ArticleYear
Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
    Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17

    Topics: Adenosine; Amnesia; Animals; Avoidance Learning; Diuretics; Male; Mice; Motor Activity; Phenylisopropyladenosine; Rats; Rats, Wistar; Receptors, Purinergic; Scopolamine; Structure-Activity Relationship; Xanthines

1993